Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia

4 páginas

Autores:
Romero Sánchez, C.
Londoño Patiño, John Darío
Delgado, G.
Jaimes Fernández, Diego Alejandro
Mora Saboyá, Eduardo Alfonso
Ávila Portillo, Luz Mabel
Castellanos, J.
Valle Oñate, R.
Briceño Balcázar, Ignacio
Tipo de recurso:
Fecha de publicación:
2011
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
eng
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/33353
Acceso en línea:
https://link.springer.com/article/10.1007%2Fs00296-011-1883-1
https://link.springer.com/content/pdf/10.1007/s00296-011-1883-1.pdf
http://hdl.handle.net/10818/33353
Palabra clave:
TNF Alpha
Polymorphism
Spondyloarthritides
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International
id REPOUSABA2_f33300cf0ac76543577e8b1b9e9895d1
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/33353
network_acronym_str REPOUSABA2
network_name_str Repositorio Universidad de la Sabana
repository_id_str
spelling Romero Sánchez, C.Londoño Patiño, John DaríoDelgado, G.Jaimes Fernández, Diego AlejandroMora Saboyá, Eduardo AlfonsoÁvila Portillo, Luz MabelCastellanos, J.Valle Oñate, R.Briceño Balcázar, Ignacio7/16/2018 14:472018-07-16T19:47:22Z2011https://link.springer.com/article/10.1007%2Fs00296-011-1883-1https://link.springer.com/content/pdf/10.1007/s00296-011-1883-1.pdfhttp://hdl.handle.net/10818/3335310.1007/s00296-011-1883-14 páginasThe pathogenesis of SpA is considered to be a complex and multi-factorial process and, similar to other autoimmune diseases, includes the activity of proinflammatory cytokines such as TNF alpha. Our study compared the -308 promoter polymorphism of TNF alpha with TNF alpha levels, HLA-B27 status, age at the onset of symptoms, SpA subtype and the clinical degree of activity in Colombian SpA patients and healthy subjects (HS). Comparisons of the TNF alpha-308A genotype among HS and SpA patients (P = 0.004), uSpA patients (P = 0.040), ReA patients (P = 0.001), were significantly different and AS patients (P = 0.110), as were alleles for SpAs (P = 0.007) between patients with SpAs and controls. Initial exploratory analyses demonstrated that the TNF alpha-308 SNP genotype frequencies were different among SpA patients and HS in the Colombian population studied. Furthermore, there was no significant correlation with activity and functional clinical index, serum TNF alpha level or HLA B27 status. Allele frequencies, on the other hand, were correlated with the activity clinical index.application/pdfengJCR Journal of Clinical RheumatologyJCR Journal of Clinical Rheumatology 16(3):S3-S3Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Universidad de La SabanaIntellectum Repositorio Universidad de La SabanaTNF AlphaPolymorphismSpondyloarthritidesAssociation of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in ColombiaarticlepublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81223https://intellectum.unisabana.edu.co/bitstream/10818/33353/2/license_rdf7c9ab7f006165862d8ce9ac5eac01552MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/33353/3/license.txtf52a2cfd4df262e08e9b300d62c85cabMD5310818/33353oai:intellectum.unisabana.edu.co:10818/333532022-05-10 05:16:42.636Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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
dc.title.es_CO.fl_str_mv Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
title Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
spellingShingle Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
TNF Alpha
Polymorphism
Spondyloarthritides
title_short Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
title_full Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
title_fullStr Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
title_full_unstemmed Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
title_sort Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia
dc.creator.fl_str_mv Romero Sánchez, C.
Londoño Patiño, John Darío
Delgado, G.
Jaimes Fernández, Diego Alejandro
Mora Saboyá, Eduardo Alfonso
Ávila Portillo, Luz Mabel
Castellanos, J.
Valle Oñate, R.
Briceño Balcázar, Ignacio
dc.contributor.author.none.fl_str_mv Romero Sánchez, C.
Londoño Patiño, John Darío
Delgado, G.
Jaimes Fernández, Diego Alejandro
Mora Saboyá, Eduardo Alfonso
Ávila Portillo, Luz Mabel
Castellanos, J.
Valle Oñate, R.
Briceño Balcázar, Ignacio
dc.subject.es_CO.fl_str_mv TNF Alpha
Polymorphism
Spondyloarthritides
topic TNF Alpha
Polymorphism
Spondyloarthritides
description 4 páginas
publishDate 2011
dc.date.issued.none.fl_str_mv 2011
dc.date.available.none.fl_str_mv 2018-07-16T19:47:22Z
dc.date.accessioned.none.fl_str_mv 7/16/2018 14:47
dc.type.en.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.hasVersion.es_CO.fl_str_mv publishedVersion
dc.identifier.other.none.fl_str_mv https://link.springer.com/article/10.1007%2Fs00296-011-1883-1
https://link.springer.com/content/pdf/10.1007/s00296-011-1883-1.pdf
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10818/33353
dc.identifier.doi.none.fl_str_mv 10.1007/s00296-011-1883-1
url https://link.springer.com/article/10.1007%2Fs00296-011-1883-1
https://link.springer.com/content/pdf/10.1007/s00296-011-1883-1.pdf
http://hdl.handle.net/10818/33353
identifier_str_mv 10.1007/s00296-011-1883-1
dc.language.iso.es_CO.fl_str_mv eng
language eng
dc.relation.ispartofseries.none.fl_str_mv JCR Journal of Clinical Rheumatology 16(3):S3-S3
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.es_CO.fl_str_mv application/pdf
dc.publisher.es_CO.fl_str_mv JCR Journal of Clinical Rheumatology
dc.source.es_CO.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
bitstream.url.fl_str_mv https://intellectum.unisabana.edu.co/bitstream/10818/33353/2/license_rdf
https://intellectum.unisabana.edu.co/bitstream/10818/33353/3/license.txt
bitstream.checksum.fl_str_mv 7c9ab7f006165862d8ce9ac5eac01552
f52a2cfd4df262e08e9b300d62c85cab
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Intellectum Universidad de la Sabana
repository.mail.fl_str_mv contactointellectum@unisabana.edu.co
_version_ 1811952264770748416